Bourrie, Bernard,Casellas, Pierre,Cosnier-Pucheu, Sylvie,Jegham, Samir,Perreaut, Pierre
申请号：
AU2013231227
公开号：
AU2013231227A1
申请日:
2013.03.13
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5- ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.
